BriaCell Therapeutics Corp’s recent filing unveils that its Director Lustig Marc acquired Company’s shares for reported $2.0 million on May 14 ’24. In the deal valued at $2.21 per share,902,935 shares were bought. As a result of this transaction, Lustig Marc now holds 2,542,935 shares worth roughly $2.14 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
H.C. Wainwright initiated its BriaCell Therapeutics Corp [BCTX] rating to a Buy in a research note published on February 14, 2022; the price target was $25.
Price Performance Review of BCTX
On Friday, BriaCell Therapeutics Corp [NASDAQ:BCTX] saw its stock fall -0.64% to $0.84. Over the last five days, the stock has lost -14.91%. BriaCell Therapeutics Corp shares have fallen nearly -85.65% since the year began. Nevertheless, the stocks have fallen -84.45% over the past one year. While a 52-week high of $5.97 was reached on 01/02/24, a 52-week low of $0.46 was recorded on 09/16/24. SMA at 50 days reached $0.7582, while 200 days put it at $1.9687.
Levels Of Support And Resistance For BCTX Stock
The 24-hour chart illustrates a support level at 0.8088, which if violated will result in even more drops to 0.7780. On the upside, there is a resistance level at 0.8737. A further resistance level may holdings at 0.9078. The Relative Strength Index (RSI) on the 14-day chart is 49.17, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0986, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 76.69%. Stochastics %K at 23.49% indicates the stock is a holding.
How much short interest is there in BriaCell Therapeutics Corp?
A steep rise in short interest was recorded in BriaCell Therapeutics Corp stocks on 2024-09-30, growing by 0.2 million shares to a total of 0.45 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-30 was 0.25 million shares. There was a rise of 43.42%, which implies that there is a positive sentiment for the stock.
